Yang et al. conducted research investigating the impact of TPL on oral cancer and noted that it exerts an inhibitory influence on the expression of DcR3 and the transcription factor metastasis-associated protein 1 (MTA1) in ex vivo and preclinical patient-derived xenograft tumor (PDTX) models [105]. Here, TNFRSF6B is linked to neoplasm.